The National Mental Health Survey (NMHS) and studies based on the Global Burden of Disease 2013 data, published as part of the China-India Lancet series, had earlier estimated the burden of mental, neurological, and substance use disorders in India. Commissioned by the Government of India in 2014–15, the NMHS covered a representative population of 39 532 individuals from 12 states across six regions of India and estimated the prevalence of mental, neurological, and substance use disorders, identifying treatment gaps and existing patterns of health-care seeking and service use. Moving a step forward, in The Lancet Psychiatry, the study by the India State-Level Disease Burden Initiative Mental Disorders Collaborators provides comprehensive estimates of the prevalence and disease burden due to mental disorders for every state of India from 1990 to 2017, on the basis of all accessible data sources and using the standard Global Burden of Disease Study methodology. According to this study, one in every seven Indians was affected by mental disorders (197·3 million people, 95% uncertainty interval [UI] 178·4–216·4), the proportional contribution of mental disorders to the total disease burden in India almost doubled from 1990 to 2017 (increasing from 2·5%, 95% UI 2·0–3·1, in 1990 to 4·7%, 3·7–5·6, in 2017), and marked regional variations in the prevalence of disorders were observed. However, this study excluded neurological disorders, such as dementia and epilepsy, and substance use disorders, which have substantial behavioural manifestations, and did not include burden associated with suicide in the overall estimates. Therefore, the burden of mental disorders described in this study is very likely to be an underestimate of the total burden due to mental, neurological, and substance use disorders in the Indian population.

中文翻译：

---

印度精神健康不堪重负：现在该采取行动了。

作为《中印柳叶刀》系列研究的一部分，国家精神卫生调查（NMHS）和基于《 2013年全球疾病负担》数据的研究较早地估计了印度的精神，神经和药物滥用疾病的负担。NMHS由印度政府于2014-15年度委托，涵盖了来自印度六个地区12个州的39 532人的代表性人口，并估计了精神，神经和药物使用障碍的患病率，确定了治疗差距和现有的模式寻求医疗保健和服务使用。在《柳叶刀精神病学》中向前迈进了一步，由印度国家级疾病负担倡议精神障碍合作者进行的研究根据所有可访问的数据来源并使用该标准，对1990年至2017年印度每个州的精神障碍患病率和疾病负担进行了全面估计全球疾病负担研究方法。根据这项研究，每七名印度人中就有一名受到精神障碍的影响（197·300万人，不确定性区间为95％[UI] 178·4–216·4）。从1990年到2017年，印度几乎翻了一番（从1990年的2·5％，95％用户界面2·0-3·1增加到2017年的4·7％，3·7-5·6），并且地区差异明显在患病率中被观察到。但是，这项研究排除了神经系统疾病，例如痴呆和癫痫，和物质使用障碍，这些行为具有实质性的行为表现，并且在总体估算中未包括与自杀相关的负担。因此，本研究中描述的精神障碍负担很可能是低估了印度人口中由于精神，神经和物质使用障碍引起的总负担。